STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹602 Cr | ₹621 Cr | ₹1,210 Cr | ₹966 Cr | ₹1,264 Cr |
What is the latest Total Non-Current Liabilities ratio of STRIDES PHARMA SCIENCE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹621 Cr |
| Mar2023 | ₹1,210 Cr |
| Mar2022 | ₹966 Cr |
| Mar2021 | ₹1,264 Cr |
How is Total Non-Current Liabilities of STRIDES PHARMA SCIENCE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹602 Cr | -3.19 | |
| Mar2024 | ₹621 Cr | -48.65 | |
| Mar2023 | ₹1,210 Cr | 25.33 | |
| Mar2022 | ₹966 Cr | -23.63 | |
| Mar2021 | ₹1,264 Cr | - | |
Compare Total Non-Current Liabilities of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹8,366.2 Cr | 3.6% | 4.4% | 42.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | 3.6% |
4.4% |
42.8% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses